Analystreport

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) had its price target raised by analysts at Truist Financial Co. from $22.00 to $25.00.

Concert Pharmaceuticals, Inc.  (CNCE) 
Last concert pharmaceuticals, inc. earnings: 4/30 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.concertpharma.com/investor-relations